Skip to main content

New Future Market Insights Report Explores Impact of COVID-19 Outbreak on High Flow Nasal Cannula Market

Market research company Future Market Insights' projections on the high flow nasal cannula market reveal that the market is slated to be valued at ~US$ 18 Bn by 2030.
Growing prevalence of respiratory disorders have led to an increase in the uptake of high-flow nasal cannula (HFNC) devices. The Center for Disease Control and Prevention (CDC) acknowledges the high-flow nasal cannula oxygenation therapy as a standard recommended therapy across the United States, especially during the COVID-19 pandemic.
Following this development, healthcare providers are facilitating extensive research on how to better integrate this technology in providing relief for severely infected patients. In the pre-COVID-19 scenario, HFNC was being administered to patients with acute respiratory distress syndrome (ARDS) and acute lung injury (ALI). These conditions were responsible for a majority of respiratory casualties.
Such extensive applications to correct respiratory anomalies is anticipated to sustain the market demand for HFNC treatment solutions and devices throughout the forecast period.
"While COVID-19 is the primary growth accelerator for the short-term, prevalence of other chronic respiratory ailments will sustain HFNC demand for the remaining forecast," opines an FMI analyst.
For more insights into the Market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11269
Key Takeaways from FMI's High Flow Nasal Cannula Market Report
  • North America and Europe shall capture half of the HFNC market
  • E-commerce to be the most widely used channels for HFNC device delivery due to preference for contactless transactions
  • Homecare settings to extensively use HFNC treatment devices
  • Infant bronchitis and pneumocephalus to generate fertile ground for HFNC treatment during 2020-2030
  • Single-use nasal cannulas gain traction during the COVID-19 crisis
  • High flow nasal cannula market shall expand at over 12% CAGR in 2020
High Flow Nasal Cannula Market- Key Trends
  • Continuous product launches to flood the global HFNC market as vendors look to acquire a competitive edge over their rivals
  • Smooth oxygen delivery of heated, humidified oxygen at a flow rate of 60 liters per minute makes HFNC an ideal treatment method for respiratory patients
  • Partnerships and collaborations with research institutions and hospitals are increasing in order to provide treatment for severely affected COVID-19 patients
High Flow Nasal Cannula Market: Region-wise Analysis
  • Single-use HFNC devices are gaining traction across the German, Japanese and English markets respectively
  • The United States market shall expand at over 10% CAGR by 2020-end
  • Growing healthcare literacy amongst the population shall propel HFNC usage in India and China
  • Japan dominates the East-Asian high flow nasal cannula market
High Flow Nasal Cannula Market: Competitive Landscape
The high flow nasal cannula market is characterized by the presence of numerous players, making the market highly fragmented. The players are capitalizing on new product launches to acquire a market foothold.
For instance, in Jan 2019, ResMed unveiled its MOBI portable oxygen concentrator across the US market to address patients suffering from chronic obstructive pulmonary disease (COPD). Later that year, in May 2019, Fisher & Paykel Healthcare Ltd. launched the Optiflow 3S nasal cannula technology.
Likewise, Teleflex launched the Hudson RCI Comfort Flo Plus Cannula which concentrates on administering oxygen to the upper airway dead space, providing a greater level of comfort.
For information on the research approach used in the report, request methodology@ https://www.futuremarketinsights.com/askus/rep-gb-11269
High Flow Nasal Cannula Market Taxonomy
Component
  • Air/Oxygen Blender
  • Active Humidifier
  • Nasal Cannulas
  • Heated Inspiratory Circuit
  • Consumables
Medical Application
  • Acute Respiratory Failure
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Bronchiectasis
  • Carbon Monoxide Toxicity
  • Sleep Apnea
  • Acute Heart Failure
  • Others
End User
  • Hospitals
  • Specialty Clinics
  • Long-term Care Centers
  • Ambulatory Care Centers
  • Homecare Settings
Region/Country
North America
  • U.S
  • Canada
Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of LATAM
Europe
  • EU-5
  • Russia
  • Rest of Europe
South Asia
  • India
  • Thailand
  • Indonesia
  • Malaysia
  • Rest of South Asia
East Asia
  • China
  • Japan
  • South Korea
Oceania
  • Australia
  • New Zealand
Middle East & Africa (MEA)
  • GCC
  • South Africa
  • Rest of MEA

Comments

Post a Comment

Popular posts from this blog

Frozen Foods Market Demand, Supply, Growth Factors, Latest Rising Trend and Forecast to 2032

 The Frozen Foods Market has experienced a significant transformation in recent years and continues to be a prominent and dynamic segment of the global food industry. As we move into 2033, this market remains a crucial part of modern lifestyles, offering a wide variety of convenient and preserved food options for consumers. The growth of the Frozen Foods Market is fueled by changing consumer preferences, technological innovations, and an ever-increasing demand for convenient, time-saving, and nutritious meal solutions. In 2033, the Frozen Foods Market is expected to continue its upward trajectory, as more consumers seek the benefits of frozen products. This market encompasses an extensive range of items, from frozen vegetables and fruits to ready-to-eat meals, appetizers, and desserts. The versatility and extended shelf life of frozen foods have made them an essential staple in many households. Consumers are drawn to the convenience of having quick, easy-to-prepare, ...
Post a Comment
Read more

Epilepsy Treatment Market Share and Growth Factors Impact Analysis 2032

 The Epilepsy Treatment Market is a critical segment of the healthcare industry dedicated to addressing the needs of individuals suffering from epilepsy, a neurological disorder characterized by recurrent seizures. Epilepsy affects millions of people globally, making it a significant public health concern. The market encompasses a wide range of treatment options, including antiepileptic drugs (AEDs), surgery, and various non-pharmacological approaches. One of the primary drivers of the epilepsy treatment market is the continuous development of novel and more effective antiepileptic medications. Pharmaceutical companies are investing in research and development to create AEDs with improved efficacy, fewer side effects, and better patient compliance. These advancements have provided patients with a broader selection of treatment options, enhancing their quality of life and reducing the frequency and intensity of seizures. Surgical interventions, such as resective surg...
Post a Comment
Read more

Global ADAS Calibration Equipment Market Projected to Witness a Measurable Downturn; COVID-19 Outbreak Remains a Threat to Growth in the Near Future

  ADAS Calibration Equipment Market Analysis 2019 - 2029 A recent market study published by FMI on the ADAS calibration equipment market includes global industry analysis for 2014 - 2018 & opportunity assessment for 2019-2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical as well as current growth parameters of the ADAS calibration equipment market, the growth prospects of the market are obtained with maximum precision. ADAS Calibration Equipment Market Taxonomy The global ADAS calibration equipment market is segmented in detail to cover every aspect of the market and present complete market intelligence to the reader. Vehicle Passenger Vehicles Commercial Vehicles End User Automotive OEMs Tier 1 Suppliers Service Stations Region North America Latin America Europe South Asia East Asia Oceania Middle East and Africa For more insights into the Market, request a sample of this report@  ...
Post a Comment
Read more